TG Branfalt

A new law in Delaware will let physicians certify patients for medical cannabis even if they don’t have one of the state program’s qualifying conditions — patients thusly approved, however, must have a severe and debilitating condition and all standard care practices must be exhausted.

A new experimental cannabis marketplace in The Netherlands will require all distributed cannabis products to utilize plain white, “unattractive” packaging that includes health warnings and only black Helvetica font.

A proposal in San Diego, California would ban cannabis billboards within 1,000 feet of schools, playgrounds, public parks, daycare centers, and youth centers.

Canada’s cannabis industry contributed $8.26 billion to the country’s national gross domestic product as of July; that rise corresponds with a decline in other traditional industries, like mining, construction, and manufacturing.

A $1 million private donation to the Oregon State University’s Global Hemp Innovation Center will fund research into hemp’s industrial applications and use in consumer goods and health products.

The first adult-use cultivation licenses have been awarded in Illinois; shops are expected to open their doors to adult-use customers on January 1, 2020.

A Kentucky hemp farm is suing an Oregon hemp seed supplier over $44 million in lost profits after the Oregon firm allegedly failed to provide feminized seeds during a cross-country, 6-million hemp seed deal.

Connecticut health officials have recommended adding chronic pain and Ehlers-Danlos syndrome as qualifying conditions for the state’s medical cannabis program.

77 percent of patients affected by the vape-linked pulmonary illness were using vaporizers containing both THC and nicotine; “nearly all” of the cannabis vape products, however, were obtained from “friends, family members, illicit dealers, or off the street.”

Kentucky hemp applications are set to open in about a month; interested farmers will have until March 15, 2020, to submit applications.

GW Pharmaceuticals is partnering up with New York’s Montefiore Medical Center to study CBDV, or cannabidivarin, as a treatment for autism.

A hemp farm in Whitefield, Maine has opened its doors as a pick-your-own establishment; it’s the first farm in Maine to do so and is believed to be the second publicly accessible hemp farm in the nation.

In light of the Australian Capital Territory’s recent legalization reforms, the country’s Health Minister confirmed that federal officials have “no plans” to fight the new legislation.

Maryland’s latest medical cannabis licensing round has been delayed due to an allegedly flawed application process that blocked many applicants from submitting all of the necessary materials on time.

Meg Sanders is co-founder of the Canna Provisions Group — a boutique dispensary in Lee, Massachusetts — and co-owner of the successful MiNDFUL dispensary brand in Colorado.

Pennsylvania Gov. Tom Wolf has formally announced his support for adult-use cannabis legalization and called for lawmakers to craft legislation to end cannabis prohibition in the state.

The latest round of medical cannabis reforms in Massachusetts has done away with the $50 annual patient registration fee.

A CBD shop in Chicago is suing its landlord after being told they couldn’t display their logo, which contains a hemp leaf, on local signage because the landlords claim it would promote “marijuana usage.”

Massachusetts regulators voted 4-1 in favor of home delivery and social consumption rules; licenses for the two new business types will be made available first to social equity and economic empowerment applicants.

Lawmakers in the Australian Capital Territory have passed legislation legalizing adult-use cannabis and home cultivation; the new rules do not, however, approve any form of cannabis distribution, including sales and gifts.

A governor-issued ban in Massachusetts will block the sale of cannabis and nicotine vaporizer products for four months; the ban comes after 61 people in the state have fallen ill with the vape-related pulmonary illness.

The products are Ground Flower Pods from Curaleaf, they are meant for use with a vaporizer, and it’s the first cannabis flower product to be available under New York’s medical cannabis program.

New Hampshire lawmakers have blocked a governor veto against medical cannabis expansions in the state; the veto would have cemented the state’s three-month waiting period before approved cannabis patients could access their medicine.

The European Union has approved Epidiolex for the treatment of two childhood epilepsy conditions. It’s the first time the EU has approved a cannabis-based medication.